While you’re busy scaling up your bioprocesses, don’t forget about the secure supply of all critical raw materials

How can we overcome red tape and roadblocks to ensure a steady supply of pharmaceutical ingredients?

Can newly discovered antibodies help us do away with annual flu vaccinations?

After other defendants in the case settle, Teva is left to face the music in New York alone.

To keep biosimilars costs as low as possible, take a good look at your purification and characterization processes.

A technique comparable to the alternative medicinal practice of “cupping” has shown potential in improving delivery of nucleic acid medicines.

A new report has exposed a Humira US price hike that dwarfs the rises in the price of other drugs.

Experts explain how cell therapies can tackle tumors in our 2021 supplement on cell and gene therapies.

How can we improve transdermal packaging options for the Indian pharmaceutical market?

How can we support women's careers in pharmaceutical sciences?